METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM
FIELD: medicine. SUBSTANCE: method involves measuring spontaneous (SCL) and induced (ICL) chemoluminescence and their ratio (RCL), antioxidation blood plasma activity, malonic dialdehyde contents in it, proteinases and elastase alpha1-inhibitor level. The like mean values in norm are also determined...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SURKOVA E.A KOTENKO T.V TSJURA E.V ORLOVA G.P MALYSHEV M.E SES' T.P |
description | FIELD: medicine. SUBSTANCE: method involves measuring spontaneous (SCL) and induced (ICL) chemoluminescence and their ratio (RCL), antioxidation blood plasma activity, malonic dialdehyde contents in it, proteinases and elastase alpha1-inhibitor level. The like mean values in norm are also determined. Integral index (K) is built by using formula K=Ax/Ak+Bx/Bk+Cx/Ck, where Ax, Bx, Cx are the mean values of coefficient of patient under examination, Ax, Bx, Cx are the mean values of coefficient in norm, A is the spontaneous-to-induced chemoluminescence ratio, B is the ratio of antioxidation blood plasma activity to malonic dialdehyde contents, C is the proteinases and elastase alpha1-inhibitor levels ratio. K being less than 125, inflammatory process availability in bronchopneumonic system is diagnosed. The integral index value K=110-120 and ICL=15-25, pneumoconiosis diagnosis is to be set. K=100-110 and ICL=6-10, pneumoconiosis diagnosis is to be set. K=100-110 and ICL= 50-70, toxic fibrosing alveolitis diagnosis is to be set. EFFECT: accelerated analysis method; higher reproducibility and reliability of results. 4 cl, 1 tbl |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2131608C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2131608C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2131608C13</originalsourceid><addsrcrecordid>eNrjZHD3dQ3x8HdRcPMPUnDxdHT38w_29HNX8PRz83H09XUM8fT3UwgI8nd2DQ52DQYKKzgF-fs5e_gH-LmG-vr7eTorBEcGh7j68jCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-KBQI0NjQzMDC2dDYyKUAAC1qyy-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM</title><source>esp@cenet</source><creator>SURKOVA E.A ; KOTENKO T.V ; TSJURA E.V ; ORLOVA G.P ; MALYSHEV M.E ; SES' T.P</creator><creatorcontrib>SURKOVA E.A ; KOTENKO T.V ; TSJURA E.V ; ORLOVA G.P ; MALYSHEV M.E ; SES' T.P</creatorcontrib><description>FIELD: medicine. SUBSTANCE: method involves measuring spontaneous (SCL) and induced (ICL) chemoluminescence and their ratio (RCL), antioxidation blood plasma activity, malonic dialdehyde contents in it, proteinases and elastase alpha1-inhibitor level. The like mean values in norm are also determined. Integral index (K) is built by using formula K=Ax/Ak+Bx/Bk+Cx/Ck, where Ax, Bx, Cx are the mean values of coefficient of patient under examination, Ax, Bx, Cx are the mean values of coefficient in norm, A is the spontaneous-to-induced chemoluminescence ratio, B is the ratio of antioxidation blood plasma activity to malonic dialdehyde contents, C is the proteinases and elastase alpha1-inhibitor levels ratio. K being less than 125, inflammatory process availability in bronchopneumonic system is diagnosed. The integral index value K=110-120 and ICL=15-25, pneumoconiosis diagnosis is to be set. K=100-110 and ICL=6-10, pneumoconiosis diagnosis is to be set. K=100-110 and ICL= 50-70, toxic fibrosing alveolitis diagnosis is to be set. EFFECT: accelerated analysis method; higher reproducibility and reliability of results. 4 cl, 1 tbl</description><edition>6</edition><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990610&DB=EPODOC&CC=RU&NR=2131608C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990610&DB=EPODOC&CC=RU&NR=2131608C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SURKOVA E.A</creatorcontrib><creatorcontrib>KOTENKO T.V</creatorcontrib><creatorcontrib>TSJURA E.V</creatorcontrib><creatorcontrib>ORLOVA G.P</creatorcontrib><creatorcontrib>MALYSHEV M.E</creatorcontrib><creatorcontrib>SES' T.P</creatorcontrib><title>METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM</title><description>FIELD: medicine. SUBSTANCE: method involves measuring spontaneous (SCL) and induced (ICL) chemoluminescence and their ratio (RCL), antioxidation blood plasma activity, malonic dialdehyde contents in it, proteinases and elastase alpha1-inhibitor level. The like mean values in norm are also determined. Integral index (K) is built by using formula K=Ax/Ak+Bx/Bk+Cx/Ck, where Ax, Bx, Cx are the mean values of coefficient of patient under examination, Ax, Bx, Cx are the mean values of coefficient in norm, A is the spontaneous-to-induced chemoluminescence ratio, B is the ratio of antioxidation blood plasma activity to malonic dialdehyde contents, C is the proteinases and elastase alpha1-inhibitor levels ratio. K being less than 125, inflammatory process availability in bronchopneumonic system is diagnosed. The integral index value K=110-120 and ICL=15-25, pneumoconiosis diagnosis is to be set. K=100-110 and ICL=6-10, pneumoconiosis diagnosis is to be set. K=100-110 and ICL= 50-70, toxic fibrosing alveolitis diagnosis is to be set. EFFECT: accelerated analysis method; higher reproducibility and reliability of results. 4 cl, 1 tbl</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD3dQ3x8HdRcPMPUnDxdHT38w_29HNX8PRz83H09XUM8fT3UwgI8nd2DQ52DQYKKzgF-fs5e_gH-LmG-vr7eTorBEcGh7j68jCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-KBQI0NjQzMDC2dDYyKUAAC1qyy-</recordid><startdate>19990610</startdate><enddate>19990610</enddate><creator>SURKOVA E.A</creator><creator>KOTENKO T.V</creator><creator>TSJURA E.V</creator><creator>ORLOVA G.P</creator><creator>MALYSHEV M.E</creator><creator>SES' T.P</creator><scope>EVB</scope></search><sort><creationdate>19990610</creationdate><title>METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM</title><author>SURKOVA E.A ; KOTENKO T.V ; TSJURA E.V ; ORLOVA G.P ; MALYSHEV M.E ; SES' T.P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2131608C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SURKOVA E.A</creatorcontrib><creatorcontrib>KOTENKO T.V</creatorcontrib><creatorcontrib>TSJURA E.V</creatorcontrib><creatorcontrib>ORLOVA G.P</creatorcontrib><creatorcontrib>MALYSHEV M.E</creatorcontrib><creatorcontrib>SES' T.P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SURKOVA E.A</au><au>KOTENKO T.V</au><au>TSJURA E.V</au><au>ORLOVA G.P</au><au>MALYSHEV M.E</au><au>SES' T.P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM</title><date>1999-06-10</date><risdate>1999</risdate><abstract>FIELD: medicine. SUBSTANCE: method involves measuring spontaneous (SCL) and induced (ICL) chemoluminescence and their ratio (RCL), antioxidation blood plasma activity, malonic dialdehyde contents in it, proteinases and elastase alpha1-inhibitor level. The like mean values in norm are also determined. Integral index (K) is built by using formula K=Ax/Ak+Bx/Bk+Cx/Ck, where Ax, Bx, Cx are the mean values of coefficient of patient under examination, Ax, Bx, Cx are the mean values of coefficient in norm, A is the spontaneous-to-induced chemoluminescence ratio, B is the ratio of antioxidation blood plasma activity to malonic dialdehyde contents, C is the proteinases and elastase alpha1-inhibitor levels ratio. K being less than 125, inflammatory process availability in bronchopneumonic system is diagnosed. The integral index value K=110-120 and ICL=15-25, pneumoconiosis diagnosis is to be set. K=100-110 and ICL=6-10, pneumoconiosis diagnosis is to be set. K=100-110 and ICL= 50-70, toxic fibrosing alveolitis diagnosis is to be set. EFFECT: accelerated analysis method; higher reproducibility and reliability of results. 4 cl, 1 tbl</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_RU2131608C1 |
source | esp@cenet |
subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
title | METHOD FOR DIAGNOSING INFLAMMATION PROCESSES IN BRONCHOPNEUMONIC SYSTEM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T18%3A29%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SURKOVA%20E.A&rft.date=1999-06-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2131608C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |